Ddrops® Championed Active Childhoods and Healthy Growth at Aqua Champs League Fest 2026 Malaysia

by | PRNewswire Asia

KUALA LUMPUR, Malaysia, June 14, 2026 /PRNewswire/ — Ddrops®, a Canadian family health and nutritional supplement brand, participated as a supporting sponsor of Aqua Champs League Fest 2026 (ACLF 2026) in Malaysia, reinforcing its commitment to...

Luxel Corporation Appoints KOS, Inc. as Exclusive Distributor in South Korea

by | PRNewswire Asia

FRIDAY HARBOR, Wash., June 13, 2026 /PRNewswire/ — Luxel Corporation, a global leader in the design and manufacture of ultrathin freestanding polymer and metallized optical bandpass filters, today announced the appointment of KOS, Inc. as its exclusive...

BAIC FOTON eView Connect Makes a Strong Debut in Thailand, Pioneering a New Paradigm for Green Logistics in Southeast Asia

by | PRNewswire Asia

BEIJING, June 12, 2026 /PRNewswire/ — CP FOTON recently held an official launch event in Bangkok, Thailand, to unveil its eView Connect new energy van. Senior executives from the CP Group and Foton International, along with the first batch of customers,...

From Chengdu to the World, Pernod Ricard, the worldwide leader in the spirits industry showcases Chinese Whisky "THE CHUAN" through Hong Kong

by | PRNewswire Asia

HONG KONG, June 12, 2026 /PRNewswire/ — Pernod Ricard, the worldwide leader in the spirits industry, held the "From Chengdu to the World – Showcasing Chinese Whisky through Hong Kong: THE CHUAN" press conference today. The event was graced by the...

Agoda Highlights Unique Traditional Food Destinations in Asia

by | PRNewswire Asia

SINGAPORE, June 12, 2026 /PRNewswire/ — Food remains a compelling reason for travel, drawing explorers to new destinations with the promise of authentic flavors and culinary traditions. Digital travel platform Agoda is shining a light on some of Asia’s...

Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio

by | PRNewswire Asia

HONG KONG, June 12, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab (AK111), the company’s internally-developed anti-IL-17 monoclonal antibody, for the...